Literature DB >> 26805556

The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis.

S Lembo1, N Balato1, G Caiazzo1, M Megna1, F Ayala1, A Balato1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26805556     DOI: 10.1111/jdv.13583

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  1 in total

1.  Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Authors:  Maddalena Napolitano; Luisa Costa; Francesco Caso; Matteo Megna; Raffaele Scarpa; Nicola Balato; Fabio Ayala; Anna Balato
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.